SILEXION THERAPEUTICS CORP Other Noncash Income (Expense)
SILEXION THERAPEUTICS CORP (SLXN) reported Other Noncash Income (Expense) of $135.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-14
- SILEXION THERAPEUTICS CORP other noncash income (expense) for the quarter ending 2026-06-30 was $135.00K.
- SILEXION THERAPEUTICS CORP other noncash income (expense) for the quarter ending 2026-03-31 was -$4.00K.
- SILEXION THERAPEUTICS CORP other noncash income (expense) for the quarter ending 2025-12-31 was -$50.00K, a 101.00% decline year-over-year.
- SILEXION THERAPEUTICS CORP other noncash income (expense) for the quarter ending 2025-09-30 was $16.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $135.00K 10-Q · filed 2026-08-14 | $131.00K 10-Q · filed 2026-08-14 | $81.00K derived: sum of 3 quarters · filed 2026-08-14 | $97.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$4.00K S-1/A · filed 2026-08-10 | -$54.00K derived: sum of 2 quarters · filed 2026-08-10 | -$38.00K derived: sum of 3 quarters · filed 2026-08-10 | -$267.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$50.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | -$34.00K derived: sum of 2 quarters · filed 2026-08-10 | -$263.00K derived: sum of 3 quarters · filed 2026-08-14 | -$344.00K S-1/A · filed 2026-08-10 |
| 2025-09-30 | $16.00K 10-Q · filed 2025-11-12 | -$213.00K derived: sum of 2 quarters · filed 2026-08-14 | -$294.00K 10-Q · filed 2025-11-12 | $4.72M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$229.00K 10-Q · filed 2026-08-14 | -$310.00K 10-Q · filed 2026-08-14 | $4.71M derived: sum of 3 quarters · filed 2026-08-14 | $960.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$81.00K S-1/A · filed 2026-08-10 | $4.94M derived: sum of 2 quarters · filed 2026-08-10 | $1.19M derived: sum of 3 quarters · filed 2026-08-10 | |
| 2024-12-31 | $5.02M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $1.27M derived: sum of 2 quarters · filed 2026-08-10 | $1.05M S-1/A · filed 2026-08-10 | |
| 2024-09-30 | -$3.75M 10-Q · filed 2025-11-12 | -$3.97M 10-Q · filed 2025-11-12 | ||
| 2023-12-31 | -$318.00K 8-K · filed 2025-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |